Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Milrinone in Congenital Diaphragmatic Hernia

NCT02951130 is registered in ClinicalTrials.gov with NICHD Neonatal Research Network as lead sponsor.

NCT NCT02951130
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02951130 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Milrinone in Congenital Diaphragmatic Hernia
Lead sponsor
NICHD Neonatal Research Network
Phase
Phase 2
Overall status
Completed
Start date
October 24, 2017
Completion date
May 19, 2025
Enrollment
66 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

congenital diaphragmatic hernia, hypoxemic respiratory failure, persistent pulmonary hypertension of the newborn, pulmonary hypoplasia